Oscar Health, Inc. (OSCR) - Form 8-K Summary
Business Context and Reporting Period
Oscar Health, Inc. filed this Current Report on Form 8-K on May 6, 2026, to announce its financial results for the quarter ended March 31, 2026. The Company is incorporated in Delaware and its Class A Common Stock trades on the New York Stock Exchange under the symbol OSCR.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. This Form 8-K serves as a notification that results were announced and incorporates a press release (Exhibit 99.1) by reference, but the detailed financial data is not contained within the body of this specific document.
Material Changes
The filing text does not provide specific details regarding material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The filing text does not contain specific guidance, outlook, management commentary, risks, contingencies, or unusual items. The document explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference except as expressly set forth.
Key Facts for Investor Verification
- Verify the specific revenue and loss figures in the attached Press Release (Exhibit 99.1) as they are not listed in this 8-K text.
- Confirm the Company's membership in the Emerging Growth Company status, as the checkmark box in the filing text is empty.
- Review the full text of the press release for any forward-looking statements or updated guidance not captured in this summary.
- Note that the financial results are for the quarter ended March 31, 2026, announced on May 6, 2026.